Introducing of novel class of pyrano[2,3-c]pyrazole-5-carbonitrile analogs with potent antimicrobial activity, DNA gyrase inhibition, and prominent pharmacokinetic and CNS toxicity profiles supported by molecular dynamic simulation

被引:5
作者
Almaghrabi, Mohammed [1 ]
Musa, Arafa [2 ,9 ]
Aljohani, Ahmed K. B. [1 ]
Ahmed, Hany E. A. [3 ,10 ]
Alsulaimany, Marwa [1 ]
Miski, Samar F. [4 ]
Mostafa, Ehab M. [2 ]
Hussein, Shaimaa [5 ]
Parambi, Della Grace Thomas [6 ]
Ghoneim, Mohammed M. [7 ]
Elgammal, Walid E. [8 ]
Halawa, Ahmed H. [8 ]
Hammad, Ali [3 ]
El-Agrody, Ahmed M. [8 ]
机构
[1] Taibah Univ, Coll Pharm, Pharmacognosy & Pharmaceut Chem Dept, Medina, Saudi Arabia
[2] Jouf Univ, Coll Pharm, Dept Pharmacognosy, Sakaka, Aljouf, Saudi Arabia
[3] Al Azhar Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Nasr City, Cairo, Egypt
[4] Taibah Univ, Coll Pharm, Pharmacol & Toxicol Dept, Medina, Saudi Arabia
[5] Jouf Univ, Coll Pharm, Dept Pharmacol, Sakaka, Aljouf, Saudi Arabia
[6] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka, Aljouf, Saudi Arabia
[7] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah, Saudi Arabia
[8] Al Azhar Univ, Fac Sci, Chem Dept, Nasr City, Egypt
[9] Jouf Univ, Coll Pharm, Dept Pharmacognosy, Sakaka 72341, Aljouf, Saudi Arabia
[10] Al Azhar Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Nasr City 11884, Cairo, Egypt
关键词
Pyranopyrazole; DNA gyrase; antimicrobial activity; docking; molecular dynamics; NMDA receptors; ciprofloxacin; BIOLOGICAL EVALUATION; TOPOISOMERASE-IV; DERIVATIVES; DOCKING; DESIGN; ANTIBACTERIAL; DISCOVERY; ANTIBIOTICS; AGENTS; NEUROTOXICITY;
D O I
10.1080/07391102.2023.2252088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microbiological DNA gyrase is recognized as an exceptional microbial target for the innovative development of low-resistant and more effective antimicrobial drugs. Hence, we introduced a one-pot facile synthesis of a novel pyranopyrazole scaffold bearing different functionalities; substituted aryl ring, nitrile, and hydroxyl groups. All new analogs were characterized with full spectroscopic data. The antimicrobial screening for all analogs was assessed against standard strains of Gmthornve and Gm-ve through in vitro considers. The screened compounds displayed very promising MIC/MBC values against some of the bacterial strains with broad or selective antibacterial effects. Of these, 4j biphenyl analog showed 0.5-2/2-8 mu g/mL MIC/MBC for suppression and killing of Gmthornve and Gm-ve strains. Moreover, the antimicrobial screening was assessed for the most potent analogs against certain highly resistant microbial strains. Consequently, DNA gyrase supercoiling assay was done for all analogs using ciprofloxacin as reference positive control. Obviously, the results showed a different activity profile with potent analog 4j with IC50 value 6.29 mu g/mL better than reference drug 10.2 mu g/mL. Additionally, CNS toxicity testing was done using the HiB5 cell line for attenuation of GABA/NMDA expression to both 4j and ciprofloxacin compounds that revealed better neurotransmitter modulation by novel scaffold. Importantly, docking and dynamic simulations were performed for the most active 4j analog to investigate its interaction with DNA binding sites, which supported the in vitro observations and compound stability with binding pocket. Finally, a novel scaffold pyranopyrazole was introduced as a DNA gyrase inhibitor with prominent antibacterial efficacy and low CNS side effect toxicity better than quinolones.
引用
收藏
页码:9529 / 9546
页数:18
相关论文
共 78 条
  • [1] Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors
    Abd El-Lateef, Hany M.
    Elmaaty, Ayman Abo
    Abdel Ghany, Lina M. A.
    Abdel-Aziz, Mohamed S.
    Zaki, Islam
    Ryad, Noha
    [J]. ACS OMEGA, 2023, 8 (20): : 17948 - 17965
  • [2] Antimicrobial and Antitumor Screening of Fluorescent 5,7-Dihydroxy-4-Propyl-2H-Chromen-2-One Derivatives with Docking Studies
    Abd-El-Aziz, Alaa S.
    Alsaggaf, Azhaar T.
    Rawda, M. Okasha A.
    Ahmed, Hany E. A.
    Bissessur, Rabin
    Abdelghani, Amani A.
    Afifi, Tarek H.
    [J]. CHEMISTRYSELECT, 2016, 1 (15): : 5025 - 5033
  • [3] Design, Synthesis, and Docking Studies of 4H-Chromene and Chromene Based Azo Chromophores: A Novel Series of Potent Antimicrobial and Anticancer Agents
    Afifi, Tarek H.
    Okasha, Rawda M.
    Alsherif, Heba
    Ahmed, Hany E. A.
    Abd-El-Aziz, Alaa S.
    [J]. CURRENT ORGANIC SYNTHESIS, 2017, 14 (07) : 1036 - 1051
  • [4] STRUCTURE-ACTIVITY RELATIONSHIPS AND MOLECULAR DOCKING STUDIES OF CHROMENE AND CHROMENE BASED AZO CHROMOPHORES: A NOVEL SERIES OF POTENT ANTIMICROBIAL AND ANTICANCER AGENTS
    Afifi, Tarek H.
    Okasha, Rawda M.
    Ahmed, Hany E. A.
    Ilas, Janez
    Saleh, Tarek
    Abd-El-Aziz, Alaa S.
    [J]. EXCLI JOURNAL, 2017, 16 : 868 - 902
  • [5] Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents
    Ahmed, Hany E. A.
    Ihmaid, Saleh K.
    Omar, Abdelsattar M.
    Shehata, Ahmed M.
    Rateb, Heba S.
    Zayed, Mohammed F.
    Ahmed, Sahar
    Elaasser, Mahmoud M.
    [J]. BIOORGANIC CHEMISTRY, 2018, 76 : 332 - 342
  • [6] Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels
    Al-Harbi, Lali M.
    Al-Harbi, Eman A.
    Okasha, Rawda M.
    El-Eisawy, R. A.
    El-Nassag, Mohammed A. A.
    Mohamed, Hany M.
    Fouda, Ahmed M.
    Elhenawy, Ahmed A.
    Mora, Ahmed
    El-Agrody, Ahmed M.
    El-Mawgoud, Heba K. A.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [7] Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
    An, J.
    Zuo, G. Y.
    Hao, X. Y.
    Wang, G. C.
    Li, Z. S.
    [J]. PHYTOMEDICINE, 2011, 18 (11) : 990 - 993
  • [8] [Anonymous], 2020, WHO Report on Cancer
  • [9] [Anonymous], 2013, FDA APPR DRUGS
  • [10] The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistantEscherichia coliintended for UTI treatment
    Balasubramaniyan, Sakthivel
    Irfan, Navabshan
    Senthilkumar, Chinnaiyan
    Umamaheswari, Appavoo
    Puratchikody, Ayarivan
    [J]. NEW JOURNAL OF CHEMISTRY, 2020, 44 (31) : 13308 - 13318